US extends review of Roche MS drug Ocrevus by three months
Posted: Fri Dec 30, 2016 11:46 am
Given that Ocrelizumab is a humanized version of Rituxan I suppose this report belongs here.
http://www.ms-uk.org/us-extends-review- ... ths-231216
By the way. Could be the title of this subforum changed to "Rituximab and Ocrelizumab" or something similar? Very soon Ocrevus will need a place to be discussed.
http://www.ms-uk.org/us-extends-review- ... ths-231216
By the way. Could be the title of this subforum changed to "Rituximab and Ocrelizumab" or something similar? Very soon Ocrevus will need a place to be discussed.